Stay updated on Comparing Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Comparing Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Uproleselan in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:09:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T21:49:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-20T20:38:32.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision label v3.6.6 was added to the history and the previous revision v3.6.5 was removed, updating the record's revision trail.
    Difference
    0.1%
    Check dated 2026-08-30T21:49:28.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - The study record history updated to revision v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-09T08:46:09.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The record history shows a new revision tag, v3.6.4, replacing v3.6.3, indicating an update to the study record. This update reflects a page revision rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-07-25T17:07:08.000Z thumbnail image

Stay in the know with updates to Comparing Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Uproleselan in AML Clinical Trial page.